Population pharmacokinetics study of remifentanil in Chinese adult patients determined by an LC-MS/MS method

International Journal of Clinical Pharmacology and Therapeutics

Volumn 46, Issue 9, 2008, Pages 477-488

  Zhang, C ^a   Zhang, L ^a   Zhang, X ^a   Yang, L ^a   Zhai, S ^a   Duan, L ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

NONMEM; Pharmacokinetics; Population; Remifentanil

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN; LORATADINE; REMIFENTANIL;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFICACY; DRUG SAFETY; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; MASS SPECTROMETRY; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE;

EID: 52149120079     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP46477     Document Type: Article

References (16)

1. Bender J, Elshout J, Selinger K et al. Determination of remifentanil in human heparinised whole blood by tandem mass spectrometry with short-column separation. J Pharm Biomed Anal. 1999; 21: 559-567.
2. Bjorksten AR, Chan C, Crankshaw DP. Determination of remifentanil in human blood by capillary gas chromatography with nitrogen-selective detection. J Chromatogr B. 2002; 775: 97-101.
3. Bossj E, Montinaro A, Lecce R et al. LC-MS determination of remifentanil in maternal and neonatal plasma. J Pharm Biomed Anal. 2006; 42: 367-371.
4. Chowdhury SK, Laudicina D, Blumenkrantz M et al. An LC-MS/MS method for the quantitation of MTIC, a bioconversion product of temozolomide in rat and dog plasma. J Pharm Biomed Anal. 1999; 19: 659-668.
5. Egan TD, Minto CF, Hermann DJ et al. Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology. 1996; 84: 821-823.
6. Egan TD, Huizinga B, Gupta S et al. Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology. 1998; 89: 562-573.
7. Grosse CM, Davis IM, Arrendale RF et al. Determination of remifentanil in human blood by liquid-liquid extraction and capillary GC-HRMS-SIM using a deuterated internal standard. J Pharm Biomed Anal. 1994; 12: 195-203.
8. Haider SH, Liang ZM, Selinger K et al. Determination of remifentanil, an ultrashort-acting opiod anesthetic, in rat blood by high performance liquid chromatography with ultraviolet detection. J Pharm Biomed Anal. 1996; 14: 1727-1732.
9. Kabbaj M, Varin F. Simultaneous solid-phase extraction combined with liquid chromatography with ultraviolet absorbance detection for the determination of remifentanil and its metabolite in dog plasma. J Chromatogr B. 2003; 783: 103-111.
10. Lotsch J. Pharmacokinetic-pharmacodynamic modeling of opioids. J Pain Sympt Manage. 2005; 29: 90-103.
11. Michelsen LG, Carl CH. The pharmacokinetics of remifentanil (J). J Clin Anesth. 1996; 8: 679-682.
12. Minto CF, Schnider TW, Egan TD et al. Influence of age and gender on the pharamcokinetics and pharmacodynamics of remifentanil. Anesthesiology. 1997; 86: 10-23.
13. Peter SA, Glass MB CHB, FFA. Remifentanil: a new opioid. J Clin Anesth. 1995; 7: 558-563.
14. Rosing H, Doyle E, Davies BE et al. High-performance liquid chromatographic determination of the novel antitumor drug topotecan and topotecan as the total of the lactone plus carboxylate forms, in human plasma. J Chromatogr B. 1995; 668: 107-115.
15. Ross AK, Davis PJ, Dear GD et al. Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures. Anesth Analg. 2001; 93: 1393-1401.
16. Westmoreland CL, Hoke JF, Sebel PS et al. Pharmacokinetics of remifentanil and its major metabolites in patients undergoing elective inpatient surgery. Anesthesiology. 1993; 79: 893-903.